The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 24, 2020

Filed:

Jul. 09, 2018
Applicant:

The Board of Regents for Oklahoma State University, Stillwater, OK (US);

Inventor:

Antonius G. P. Oomens, Stillwater, OK (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 7/00 (2006.01); C07K 14/005 (2006.01); C12Q 1/06 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C12N 7/00 (2013.01); C07K 14/005 (2013.01); C12Q 1/06 (2013.01); A61K 2039/5254 (2013.01); A61K 2039/5258 (2013.01); C12N 2760/18511 (2013.01); C12N 2760/18522 (2013.01); C12N 2760/18523 (2013.01); C12N 2760/18534 (2013.01); C12N 2760/18562 (2013.01); G01N 2333/115 (2013.01); G01N 2500/00 (2013.01);
Abstract

Highly antigenic yet safe vaccines against diseases caused by Paramyxoviridae viruses such as respiratory syncytial virus (RSV) are provided. The vaccines comprise attenuated Paramyxoviridae viruses with high antigenicity but which display impaired cell-to-cell transmission as a result of genetic manipulation of the gene encoding the matrix (M) protein. In the viruses, the M protein is absent or mutated to a less active form. Screening or assay systems and methods for evaluating the infectivity of mutant M proteins anf for identifying suitable M candidates for live-attenuated vaccine virus and VLP production, are also provided.


Find Patent Forward Citations

Loading…